Exploring the Molecular Mechanism of Fengliao Changweikang in the Treatment of Irritable Bowel Syndrome Based on Network Pharmacology and Molecular Docking Technology

Corresponding author: WU Xiayang, 56425477@qq.com

DOI: 10.12201/bmr.202504.00022

•  

  Abstract: Objective: Predicting the target and mechanism of Fengliao Changweikang in treating irritable bowel syndrome based on network pharmacology and molecular docking technology. Method: Screening the effective components of Fengliao Changweikang through data mining, constructing a drug-target network using STRING and Cytoscape software to identify key targets and pathways related to irritable bowel syndrome. Perform molecular docking verification on the main active components and core action target proteins, evaluate the binding energy, and process the results for visualization. Results: Obtained 24 potential active components of Fengliao Changweikang, 134 active component target sites, 2353 disease-related target sites. After intersection, 70 potential target sites were obtained, involving 898 biological processes, 96 molecular functions, and 66 cellular components. KEGG enrichment analysis indicates that the therapeutic mechanism of Fengliao Changweikang for irritable bowel syndrome may be achieved by acting on core target points to participate in the regulation of cancer pathways, PI3K/Akt signaling pathways, phospholipase D pathways, and other key signaling pathways. Molecular docking analysis results show that the core compounds in Fengliao Changweikang have good binding activity with the core receptor protein. Conclusion: This study predicts the potential effective components, action targets, and mechanisms of Fengliao Changweikang in treating irritable bowel syndrome through network pharmacology, which can provide theoretical guidance and prediction for further research, but more relevant experiments are still needed for verification in the later stage.

  Key words: Fengliao Changweikang; network pharmacology; irritable bowel syndrome; molecular docking; Target prediction

  Submit time: 9 April 2025

  Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity.
• html

• 图表

• LI Suping, HONG Suru, WU Xiayang. Based on network pharmacology and molecular docking technology to explore the molecular mechanism of Oulongma oral drops in the treatment of allergic rhinitis. 2025. doi: 10.12201/bmr.202508.00023

  CHENG Yanyan, HE Jiayu, RUAN Yuhe, LI Zixin, ZHANG Ying. Exploration of the medication rules and mechanism of traditional Chinese medicine in treatment of cancer-related insomnia based on data mining, network pharmacology and molecular dynamics simulation.. 2025. doi: 10.12201/bmr.202510.00051

  Wei Chunshan. Exploring medication rules and mechanism for liver cancer based on data mining and network pharmacology. 2024. doi: 10.12201/bmr.202407.00040

  LIANG Ningjuan, WU Ting, YU Dandan, JIANG Xiaohan, TENG Jingjing. Effective exploration of the toxicity and molecular mechanisms of plasticisers in pulmonary fibrosis by network toxicology and molecular docking strategies: an example of butylbenzyl phthalate. 2025. doi: 10.12201/bmr.202504.00004

  Yuan Zhenzhong. Mechanism of Relieves insomnia Effect of Jiaotai Pills Based on Network Pharmacology. 2024. doi: 10.12201/bmr.202408.00069

  Wen yiqun, LU Lingjuan. Based on data mining and network pharmacology, this paper explores the medication rules of traditional Chinese medicine in the treatment of senile deafness. 2025. doi: 10.12201/bmr.202506.00077

  Wang Ken, Jiao Qingfang, Long Wenling, Zhang Zhen, Wang Hong, Yang Wanquan. Clinical efficacy and mechanism of Shenqi Shiyiwei granules in cancer-related anemia of Colon cancer based on network pharmacology. 2025. doi: 10.12201/bmr.202506.00080

  李泽明, zhoujianyong, chentingting, wangcheng, liuzhenkun, qimei, lvjiling. Exploring the mechanism of Xiaochaihu Decoction in treating cough variant asthma (CVA) based on network pharmacology and animal experiments. 2025. doi: 10.12201/bmr.202510.00009

  ZHANG Wu. Molecular mechanisms and therapeutic targets of ferroptosis in oral diseases. 2025. doi: 10.12201/bmr.202510.00005

  Liu Lingyan. Ferroptosis and endoplasmic reticulum stress in polycystic ovary syndrome and related potential therapeutic targets. 2025. doi: 10.12201/bmr.202507.00042

• ID	Submit time	Number	Download
  1	2025-03-24	10.12201/bmr.202504.00022V1	Download

• Public  Anonymous  To author only Submit Comments